Neuraxis, INC financial data

Symbol
NRXS on NYSE
Industry
Electromedical & Electrotherapeutic Apparatus
Location
11611 N. Meridian St, Suite 330, Carmel, IN
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 24 %
Quick Ratio 0.76 %
Debt-to-equity -149 %
Return On Equity 559 % +521%
Return On Assets -1.15K %
Operating Margin -383 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.84M shares
Common Stock, Shares, Outstanding 6.84M shares +248%
Common Stock, Value, Issued 6.84K USD +249%
Weighted Average Number of Shares Outstanding, Basic 6.92M shares +245%
Weighted Average Number of Shares Outstanding, Diluted 6.92M shares +245%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 477K USD -22.8%
Revenue from Contract with Customer, Excluding Assessed Tax 2.27M USD -5.34%
Research and Development Expense 103K USD -50.5%
General and Administrative Expense 10.3M USD +74.4%
Operating Income (Loss) -8.69M USD -97.5%
Net Income (Loss) Attributable to Parent -15.3M USD -135%
Earnings Per Share, Basic -2.85 USD/shares +65.3%
Earnings Per Share, Diluted -2.85 USD/shares +65.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.77M USD +3332%
Accounts Receivable, after Allowance for Credit Loss, Current 147K USD -38%
Inventory, Net 42.7K USD -3.38%
Assets, Current 2.11M USD +496%
Property, Plant and Equipment, Net 95.5K USD +12%
Operating Lease, Right-of-Use Asset 323K USD +277%
Assets 2.63M USD +71%
Accounts Payable, Current 1.12M USD -54.1%
Accrued Liabilities, Current 1.31M USD +11.6%
Liabilities, Current 7.59M USD -33.6%
Operating Lease, Liability, Noncurrent 298K USD +477%
Liabilities 7.89M USD -31.5%
Retained Earnings (Accumulated Deficit) -53.6M USD -39.8%
Stockholders' Equity Attributable to Parent -5.26M USD +47.3%
Liabilities and Equity 2.63M USD +71%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.33M USD -114%
Net Cash Provided by (Used in) Financing Activities 1.35M USD +220%
Net Cash Provided by (Used in) Investing Activities -14.7K USD -93.5%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 6.84M shares +248%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.19K USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 16.9K USD -52.9%
Deferred Tax Assets, Valuation Allowance 10.9M USD +41.9%
Operating Lease, Liability 346K USD +273%
Depreciation 7.61K USD -3.29%
Payments to Acquire Property, Plant, and Equipment 14.7K USD +93.5%
Lessee, Operating Lease, Liability, to be Paid 481K USD +315%
Property, Plant and Equipment, Gross 460K USD +10.1%
Operating Lease, Liability, Current 48.2K USD +16.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 115K USD +307%
Lessee, Operating Lease, Liability, to be Paid, Year One 111K USD +207%
Operating Lease, Weighted Average Discount Rate, Percent 0.15 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 135K USD +488%
Lessee, Operating Lease, Liability, to be Paid, Year Three 86.9K USD +199%
Deferred Tax Assets, Operating Loss Carryforwards 6.57M USD +98.6%
Preferred Stock, Shares Authorized 1.12M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 89K USD
Additional Paid in Capital 48.3M USD +70.4%
Amortization of Intangible Assets 2.62K USD +440%
Depreciation, Depletion and Amortization 10.7K USD +9.02%
Interest Expense 227K USD -58.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%